Clinical Trial Update: A Study To Evaluate the Safety, Tolerance, Pharmacokinetics/Pharmacodynamics and Efficacy of SYHA1402 Tablets For the Treatment of Patients With Diabetic Peripheral Neuropathy in China [Phase 2]

View source ↗

Summary

Phase 2 study evaluating SYHA1402 tablets for distal symmetric polyneuropathy in China; outcome details not disclosed in the provided information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Symmetric Polyneuropathy

Drugs mentioned

• SYHA1402

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Distal Symmetric Polyneuropathy (DSPN) | Phase 2 | Status: UNKNOWN